Alice Lin Pomponio, Senior Vice President of Corporate Development and Strategic Partnerships at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“Excited to be speaking on behalf of Parker Institute for Cancer Immunotherapy at UCLA LABEST 2026 on Thursday’s panel on “Challenges and Prospects for Cellular Cancer Therapies: What are the key steps to improve efficacy, durability, access to patients and cost?”
Paul Webb California Institute for Regenerative Medicine (CIRM) Kevin Cognetti Kite Pharma Zachary J Roberts MD PhD Allogene Therapeutics Antoni Ribas UCLA and PICI Center Director.
Looking for ways our ecosystem mobilizes to bring CAR T closer to patients and and widen access across patient populations and cancer types. Together we can do more.
More info here.”